113 related articles for article (PubMed ID: 34714558)
1. Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Ceriani L; Milan L; Cascione L; Gritti G; Dalmasso F; Esposito F; Pirosa MC; Schär S; Bruno A; Dirnhofer S; Giovanella L; Hayoz S; Mamot C; Rambaldi A; Chauvie S; Zucca E
Hematol Oncol; 2022 Feb; 40(1):11-21. PubMed ID: 34714558
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of bone marrow retention index and bone marrow-to-liver ratio of baseline 18F-FDG PET/CT in diffuse large B-cell lymphoma.
El-Azony A; Basha MAA; Almalki YE; Abdelmaksoud B; Hefzi N; Alnagar AA; Mahdey S; Ali IM; Nasr I; Abdalla AAEM; Yousef HY; Zaitoun MMA; Elsayed SB; Nada MG; Amin MI; Hassan RM; Ali SA; Dawoud TM; Aly SA; Algazzar YH; Abdelhamed H
Eur Radiol; 2024 Apr; 34(4):2500-2511. PubMed ID: 37812294
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial.
Schöder H; Polley MC; Knopp MV; Hall N; Kostakoglu L; Zhang J; Higley HR; Kelloff G; Liu H; Zelenetz AD; Cheson BD; Wagner-Johnston N; Kahl BS; Friedberg JW; Hsi ED; Leonard JP; Schwartz LH; Wilson WH; Bartlett NL
Blood; 2020 Jun; 135(25):2224-2234. PubMed ID: 32232481
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of
Carlier T; Frécon G; Mateus D; Rizkallah M; Kraeber-Bodéré F; Kanoun S; Blanc-Durand P; Itti E; Le Gouill S; Casasnovas RO; Bodet-Milin C; Bailly C
J Nucl Med; 2024 Jan; 65(1):156-162. PubMed ID: 37945379
[TBL] [Abstract][Full Text] [Related]
5. Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells.
Zhou Y; Zhang B; Han J; Dai N; Jia T; Huang H; Deng S; Sang S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11549-11560. PubMed ID: 37395846
[TBL] [Abstract][Full Text] [Related]
6. Baseline
Jing F; Liu Y; Zhao X; Wang N; Dai M; Chen X; Zhang Z; Zhang J; Wang J; Wang Y
EJNMMI Res; 2023 Oct; 13(1):92. PubMed ID: 37884763
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with
Wu W; Zhao L; Wang Y; Chen P; Yuan X; Miao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Jia T
Curr Probl Cancer; 2024 Feb; 48():101066. PubMed ID: 38364336
[TBL] [Abstract][Full Text] [Related]
8. SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model.
Ceriani L; Gritti G; Cascione L; Pirosa MC; Polino A; Ruberto T; Stathis A; Bruno A; Moccia AA; Giovanella L; Hayoz S; Schär S; Dirnhofer S; Rambaldi A; Martinelli G; Mamot C; Zucca E
Blood Adv; 2020 Mar; 4(6):1082-1092. PubMed ID: 32196557
[TBL] [Abstract][Full Text] [Related]
9. [The prognosis value of early and interim ¹⁸F-FDG-PET/CT scans in patients with diffuse large B-cell lymphoma].
Zhang Y; Fan Y; Yang Z; Ying Z; Song Y; Zhu J; Wang X
Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):824-9. PubMed ID: 26477759
[TBL] [Abstract][Full Text] [Related]
10. Stacking Ensemble Learning-Based [
Zhao S; Wang J; Jin C; Zhang X; Xue C; Zhou R; Zhong Y; Liu Y; He X; Zhou Y; Xu C; Zhang L; Qian W; Zhang H; Zhang X; Tian M
J Nucl Med; 2023 Oct; 64(10):1603-1609. PubMed ID: 37500261
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of
Luo Y; Huang Z; Gao Z; Wang B; Zhang Y; Bai Y; Wu Q; Wang M
Korean J Radiol; 2024 Feb; 25(2):189-198. PubMed ID: 38288898
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of CT‑based radiomics model of PET-negative residual CT masses: a potential biomarker for predicting relapse‑free survival in non-Hodgkin lymphoma patients showing complete metabolic response.
Cha SH; Kang KW; Han NY; Cho Y; Sung DJ; Park BJ; Kim MJ; Sim KC; Han YE; Sung HJ
Abdom Radiol (NY); 2024 Jan; 49(1):341-353. PubMed ID: 37884749
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT response in diffuse large B-cell lymphoma: Reader variability and association with clinical outcome.
Han EJ; O JH; Yoon H; Jung SE; Park G; Choi BO; Cho SG
Medicine (Baltimore); 2016 Sep; 95(39):e4983. PubMed ID: 27684851
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.
Kim M; Ahn SY; Ahn JS; Song GY; Jung SH; Lee JJ; Kim HJ; Lee JH; Shin MG; Song SY; Yang DH
J Korean Med Sci; 2022 Jan; 37(1):e2. PubMed ID: 34981678
[TBL] [Abstract][Full Text] [Related]
15. Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcome.
Wang F; Cui S; Lu L; Shao X; Yan F; Liu Y; He B; Wang J; Cao Y; Yue Y; Wang Y; Gu W
BMC Cancer; 2023 Nov; 23(1):1165. PubMed ID: 38030989
[TBL] [Abstract][Full Text] [Related]
16. Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma.
Driessen J; Zwezerijnen GJC; Schöder H; Kersten MJ; Moskowitz AJ; Moskowitz CH; Eertink JJ; Heymans MW; Boellaard R; Zijlstra JM
Blood Adv; 2023 Nov; 7(21):6732-6743. PubMed ID: 37722357
[TBL] [Abstract][Full Text] [Related]
17. Training and external validation of pre-treatment FDG PET-CT-based models for outcome prediction in anal squamous cell carcinoma.
Frood R; Mercer J; Brown P; Appelt A; Mistry H; Kochhar R; Scarsbrook A
Eur Radiol; 2024 May; 34(5):3194-3204. PubMed ID: 37924344
[TBL] [Abstract][Full Text] [Related]
18. A nomogram for predicting the rapid progression of diffuse large B-cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 mutations.
Liu C; Shi P; Li Z; Li B; Li Z
Cancer Med; 2023 Aug; 12(16):16734-16743. PubMed ID: 37366281
[TBL] [Abstract][Full Text] [Related]
19. Radiomics of
Mu W; Tunali I; Gray JE; Qi J; Schabath MB; Gillies RJ
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1168-1182. PubMed ID: 31807885
[TBL] [Abstract][Full Text] [Related]
20. Robust deep learning-based PET prognostic imaging biomarker for DLBCL patients: a multicenter study.
Jiang C; Qian C; Jiang Z; Teng Y; Lai R; Sun Y; Ni X; Ding C; Xu Y; Tian R
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3949-3960. PubMed ID: 37606859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
